Picture of IDL Diagnostics AB (publ) logo

IDLDX IDL Diagnostics AB (publ) Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Annual cashflow statement for IDL Diagnostics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-50.6-59.3-59.7-43.4
Depreciation
Non-Cash Items19.747.24644.2
Other Non-Cash Items
Changes in Working Capital-2.17-1.580.288-3.08-7.6
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-28.2-13.7-13.4-2.36-7.6
Capital Expenditures-0.37-4.06-1.28-0.581
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items4.91-6.06-0.001-3.61
Sale of Business
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities4.54-10.1-1.28-0.581-3.61
Financing Cash Flow Items070.60.250
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities070.60.2500
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-23.746.8-14.5-2.94-11.2